Claire Poll, General Counsel at Verona Pharma plc (VRNA), sold 160,752 shares at $2.58 ($415K) on 2023-05-01, disclosed to the SEC on 2023-05-03.
Scheduled sale ($415k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.58 | 80,376 | $207K | 50.0% |
| 2 | $2.58 | 80,376 | $207K | 50.0% |
| Total | $2.58 avg | 160,752 | $415K | 100% |
| Filing → |
| VRNA | SELL | 2023-02-03 | $394K | — | Filing → |
| VRNA | SELL | 2022-12-27 | $646K | — | Filing → |